The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...
Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.
Patients with multiple myeloma (MM) can experience diminished immune responses during prolonged treatment; however, mRNA ...
The number of layoffs in the U.S. pharmaceutical industry exceeded 14,000 last year, a 9% increase from 2023 ...
Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...
The NHS has warned of a ‘quad-demic’ as respiratory virus cases rise, so what’s the best way to kill the ‘stomach bug’ virus?